Recap of the 2023 VB100 Mini Forum CXO Beijing Session: Advancing High-Quality Development in the Medical and Health Industry
On the afternoon of April 11, hosted by VCBeat, VB100, VCBeat Research Institute, and Legend Capital, and co-organized by Beijing New Airport City Holding Co., Ltd. and Beijing New Airport City Construction Industrial Development Co., Ltd.2023 VB100 Mini Forum: CXO Beijing Special SessionThe conference concluded successfully. Distinguished guests from Haihe Biotechnology, Tonghe Litai, Sinogene, Zhenghe Qitai, Jiachuang Biotech, Xunjia Technology, Aotai Kang, Kingdee, Tigermed Jietong, Xiangkang Medicine, Legend Capital, Hongrun Health, as well as numerous industry enterprises and investment institutions, were invited to engage in in-depth discussions on the key aspects of the entire product lifecycle, spanning from project initiation, design, and manufacturing to clinical launch.
The Conference Commences,Wang Lunmao, Deputy General Manager of Beijing New Airport City Holding Co., Ltd.Delivered a welcome address, outlining a promising blueprint for the development of the Beijing Daxing International Airport Economic Zone.
Wang Lunmao, Deputy General Manager of Beijing New Airport City Holding Co., Ltd.
Xiao Peiling, Deputy General Manager of the Operation and Management Center at VCBeatIn his remarks, he stated that VCBeat continuously tracks and researches the transformations in the healthcare industry driven by global technological changes, growing alongside industry stakeholders such as enterprises, capital firms, and industrial clusters.
Xiao Peiling, Deputy General Manager of the Operation and Management Center at VCBeat
Wang Shuochun, Head of Investment Promotion for the Life and Health Industry at the Beijing Daxing Airport Economic ZoneDuring the presentation, corporate guests were showcased the high-quality environment for developing the medical and health industry at the “New Gateway International Life and Health Port—Beijing Daxing Airport Aviation City.”
Wang Shuochun, Head of Investment Promotion for the Life and Health Industry at the Beijing Daxing Airport Economic Zone
Keynote Speech: Seizing Key Elements to Gain a First-Mover Advantage in Market Launch
At the conference, industry leaders delivered compelling keynote speeches.
Fu Li, Senior Vice President of Advanced Technology at Haihe BiologicsUsing the metaphor of “seed–growth–fruit–harvest,” this section provides a macro-level, systematic overview of the different stages of a product’s full lifecycle from a global perspective.
Fu Li, Senior Vice President of Advanced Technology at Haihe Biologics
Li Wenhui, Deputy General Manager of XinuoyinShare insights on “How Genetically Modified Animal Models Play a Role in Clinical Settings,” using “Gene-Edited Dogs” as an example to demonstrate the performance of large animal models in product development and evaluation.
Li Wenhui, Deputy General Manager of Xinoyin
Yuan Bing, Technical Director of Jiachuang BiotechnologyEmphasizing that “no amount of caution regarding safety risks is excessive when applying cell therapy products to the human body,” this article shares insights into the potential risks, relevant regulations, and quality control strategies associated with cell therapy products, including stem cells and immune cells.
Yuan Bing, Technical Director of Jiachuang Biotechnology
Hu Hongping, Vice President of Xunjia TechnologyDistill the pain points and challenges in the registration and approval of Class II medical devices using the “Six Difficulties and Three Highs” framework, and summarize how startups should select CRO and CDMO partners based on the principles of “Safety, Fairness, and Professionalism.”
Hu Hongping, Vice President of Xunjia Technology
Li Yingjun, Chairman of the Expert Committee on Laboratory Animal Medicine of the Chinese Research Hospital Association, and General Manager of Beijing Tonghe Litai Biotechnology Co., Ltd.It is believed that innovative medical devices or products must possess four essential elements: core patents, internationally leading technology, innovativeness, and priority status during the regulatory approval process, with particular emphasis placed on the necessity of animal studies.
Li Yingjun, Chairman of the Expert Committee on Medical Animal Experiments, Chinese Research Hospital Association; General Manager, Beijing Tonghe Litai Biotechnology Co., Ltd.
Li Yongshun, PMP® (Project Management Professional) certified by PMI (USA), Senior Project Manager accredited by the Ministry of Information Industry, and Kingdee China Expert in Pharmaceutical Industry Solutions“Delivering a keynote on ‘How Digitalization Empowers CXO Enterprises from R&D to Production,’ showcasing through real-world cases the critical role of digitalization in enhancing corporate product competitiveness, delivery capability, customer acquisition, and compliance.”
Li Yongshun, PMP (Project Management Professional) certified by PMI (USA), Senior Project Manager certified by the Ministry of Information Industry, and Kingdee China Expert in Pharmaceutical Industry Solutions
Roundtable Dialogue: Breaking Down Communication Barriers, Building Bridges of Trust
The roundtable discussion centered on the theme, “How to Effectively Implement High Efficiency and High Quality?” It explored how to break down communication barriers and build bridges of trust. Roundtable panelists and the audience engaged in active dialogue and interaction on these topics.
Li Wei, Senior Director of Regulatory Affairs and General Manager of the Testing Laboratory at Tigermed JietongIt is stated that the starting point in communication is crucial, and when advancing a project, it is necessary to adopt perspective-taking when dealing with different stakeholders.
Wang Chengzhen, Vice President of Aotai Kang GroupOpinion: In the process of collaborating with enterprises, a supportive and learning-oriented approach is more conducive to project transformation, while also realizing self-worth.
Yi Min, Deputy General Manager of Xiangkang MedicineIndicates: When facing objections, it is necessary to provide reasonable insights from a professional perspective and adhere to recommendations to build trust.
Zuo Lin, founder of Hongrun Health, fromStarting from real-world cases, build a foundation for communication and trust through technical expertise, professionalism, and professional acumen.
Huang Jinglu, Investor at Legend CapitalIt is believed that both the client and the service provider must effectively manage expectations, oversee processes, and conduct post-project reviews. Meanwhile, conservative confidentiality measures are not a sustainable long-term strategy; for enterprises, rapid iteration to maintain an industry-leading position constitutes the most effective defense.
With this, the 2023 VB100 Mini Forum CXO Beijing Special Session has come to a close. This year, the VB100 Mini Forum has been held for three consecutive sessions, spanning Guangzhou, Shanghai, and Beijing. We look forward to sharing more industry stories from diverse fields with our peers in the healthcare sector, while providing a platform for exchange and collaboration among various stakeholders in the industry.
See you next time, friends!